Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• New treatments, increased awareness shine spotlight on cardiac amyloidosis Darlene Dobkowski, MA
• Anita W. Asgar, MD, MSc, navigates paradigm shifts in transcatheter valve therapy
• FDA approves CV risk indication for semaglutide
• FDA approves less-invasive approach for heart pump implantation
• FDA warns of possible cancer risk with obesity drug
• Leadless pacemaker for patients with atrioventricular block nets FDA approval
• BP elevations occur earlier in life for women vs. men
• Good oral hygiene may lower risk for HF, AF
• Hypertrophic cardiomyopathy may affect black patients earlier with disparities in care
• In PCI population, cancer confers mortality, bleeding risks
• Inadequate sleep, occupation may contribute to increased CHD risk
• Intensive BP reduction may reduce HF risk
• Intermittent fasting may benefit in metabolic syndrome
• Intervention improves adherence to Mediterranean diet
• Lipid levels decreased since publication of 2013 cholesterol guidelines
• Statins do not confer memory, cognition decline in older patients
• Vascular calcification present in mummies despite marine diet
• Novel antisense drug for triglyceride reduction shows positive top-line results
• STRENGTH CV outcomes trial of omega-3 fatty acid stopped for futility
• Omega-3 fatty acids for CV risk reduction: The one that did not get away Bruce Warden, PharmD, BCPS-AQ Cardiology, CLS; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• BASEL VIII
• CANDLE
• CIRCA-DOSE
• COLCHCINE PCI
• MOVE IT
• OUTSMART HF
• SIRONA
• TIGERS